ImpediMed Limited (IPD) is a medical technology Company that non-invasively measures, monitors and manages fluid status and tissue composition data using bioimpedance spectroscopy (BIS).
Find out what a historical investment in ImpediMed Call 0.01 AUD ImpediMed 31Mar27 Opt would be worth today using our IPDO stock calculator.
Buying IPDO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ImpediMed Call 0.01 AUD ImpediMed 31Mar27 Opt in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in IPDO
What is the ticker symbol of ImpediMed Call 0.01 AUD ImpediMed 31Mar27 Opt?
The ticker symbol for ImpediMed Call 0.01 AUD ImpediMed 31Mar27 Opt is IPDO.
How much is one share of IPDO?
One share of IPDO is valued at $0.00 as of 20 November 2026.
What is the market capitalisation of ImpediMed Call 0.01 AUD ImpediMed 31Mar27 Opt IPDO?
As of 20 November 2026 ImpediMed Call 0.01 AUD ImpediMed 31Mar27 Opt has a market cap of $18.33M.
What is the P/E ratio of IPDO?
The Price to Earnings ratio of IPDO is -0.09.
What is the Earnings Per Share of IPDO?
The Earnings Per Share of IPDO is -$0.01.
What is the 52-week high for ImpediMed Call 0.01 AUD ImpediMed 31Mar27 Opt stock?
The ImpediMed Call 0.01 AUD ImpediMed 31Mar27 Opt 52-week high stock price is $0.00.
What is the 52-week low for ImpediMed Call 0.01 AUD ImpediMed 31Mar27 Opt stock?
The ImpediMed Call 0.01 AUD ImpediMed 31Mar27 Opt 52-week low stock price is $0.00.
Can I buy IPDO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IPDO shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.